|
ASPDH expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.917800E-03 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.098600E-03 |
| Normal-vs-Stage2 |
6.680400E-01 |
| Normal-vs-Stage3 |
4.821700E-03 |
| Normal-vs-Stage4 |
4.878100E-02 |
| Stage1-vs-Stage2 |
4.245800E-02 |
| Stage1-vs-Stage3 |
6.783600E-01 |
| Stage1-vs-Stage4 |
9.925400E-01 |
| Stage2-vs-Stage3 |
3.231600E-02 |
| Stage2-vs-Stage4 |
1.465050E-01 |
| Stage3-vs-Stage4 |
7.884800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.785000E-03 |
| Normal-vs-AfricanAmerican |
6.008600E-01 |
| Normal-vs-Asian |
4.781300E-03 |
| Caucasian-vs-AfricanAmerican |
1.284800E-01 |
| Caucasian-vs-Asian |
8.957400E-01 |
| AfricanAmerican-vs-Asian |
1.429430E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.621230E-01 |
| Normal-vs-Female |
1.684930E-03 |
| Male-vs-Female |
1.614240E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.904400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.756220E-02 |
| Normal-vs-Age(61-80Yrs) |
3.502200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.080400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.695000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.859500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.840800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.199200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.283800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.953000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.076150E-02 |
| Classical-VS-Follicular |
2.614500E-04 |
| Classical-VS-Other |
5.549400E-01 |
| Classical-VS-Normal |
1.016210E-03 |
| Tall-VS-Follicular |
5.54939999952708E-07 |
| Tall-VS-Other |
3.690000E-01 |
| Tall-VS-Normal |
2.11629999999907E-05 |
| Follicular-VS-Other |
9.844200E-01 |
| Follicular-VS-Normal |
9.639800E-01 |
| Other-VS-Normal |
9.764800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.826200E-02 |
| Normal-vs-N1 |
7.065700E-02 |
| N0-vs-N1 |
8.538400E-01 |
|
|
